Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Mental health

Disabled children could be at risk of exploitation by criminal gangs, warns new research

Exclusive: Research suggests poor support for children with special education needs and disabilities is putting young people at risk of criminal exploitation

The Independent UK

The worrying biological changes found in rugby players who suffered several concussions

The study comes after it emerged that former All Blacks player Norm Hewitt died aged 55 with motor neurone disease

The Independent UK

Bad behaviour disorder that 5% of children could have ‘can be spotted in brain scan’

Although associated with a high burden for families, conduct disorder is one of the least researched psychiatric disorders

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

‘My brain leaves the room’: what happens when teachers talk too much?

About four students in every classroom will have a language or attention disorder. While some of these students will have an official diagnosis of developmental language disorder (DLD) or attention-deficit hyperactivity disorder (ADHD), others will be “hiding in plain sight”. These students may often be in trouble for acting out,…

The Conversation

What is the QbTest for ADHD, how long does it take for diagnosis and who can take it?

The QbTest could speed up diagnosis for young people being assessed for the three symptoms of ADHD

The Independent UK

Whistleblower Peter Buxtun – who exposed Tuskegee syphilis study – dies aged 86

For 40 years the US Public Health Service conducted a study in which black men were left untreated for syphilis

The Independent UK

Maintaining Blood Pressure Below 120 mmHg Protects From Late-Life Dementia: Study

The study revealed that lowering systolic blood pressure below the clinically safe threshold of 120 mmHg over time may slightly reduce an individual's risk of developing dementia, particularly among Black and Latino groups.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

ADHD digital test approved for NHS use in England and Wales

Experts hope QbTest will help more children get diagnosis within six months of first assessment

The Guardian - UK

‘The grief and loss is hard to bear’: the cruelty of Alzheimer’s disease

Letter: Readers respond to Michael Aylwin’s article about his wife’s dementia

The Guardian - UK

UK needs Covid-style push on dementia drugs, says ex-head of vaccine taskforce

Kate Bingham says ageing population means tackling dementia must be treated as economic imperative

The Guardian - UK

MS patients in England offered 10-minute jab in place of infusions

Ocrelizumab IV administration has taken up to five hours but injections will make ‘significant difference’

The Guardian - UK

Honoring Uncle Chip: A Tribute To Love And Resilience

Justin Baldoni's heartfelt tribute to Uncle Chip highlights resilience in the face of Alzheimer's, urging us to cherish loved ones and embrace life with gr...

Top News

Author and brain coach Jim Kwik: Knowledge is power, learning is our superpower

The bestselling writer, podcaster and entrepreneur says his learning difficulties pushed him to become a world expert on the mind. He shares his extraordinary journey with Evgeny Lebedev

Evening Standard

Night owls’ cognitive function ‘superior’ to early risers, study suggests

Research on 26,000 people found those who stay up late scored better on intelligence, reasoning and memory tests

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - US

White House releases more details on Biden’s health after press room shouting match

White House physician clarifies in letter that Biden has not seen a neurologist outside of his annual physicals

International Business Times

White House Says Biden Hasn't Seen Neurologist Outside Annual Check-Ups, Dismisses Parkinson's Rumors

The doctor's statement comes in response to speculation over visits by Dr. Kevin Cannard, a Parkinson's disease expert, to the White House.

AAP

Push to expedite common anti-depressant amid shortages

The common anti-depressant Duloxetine is in short supply with pharmaceutical companies working to expedite shipments to address concerns about its availability.

The Independent UK

White House shoots down Parkinson’s speculation with explanation of specialist doctor visits

President Biden’s physician released a memo confirming that a prominent neurologist had seen the president as part of his annual physical

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

‘Whatchamacallit’, ‘gizmo’ and ‘thingamajig’: what we say when we can’t find the right word – and why

Over 50,000 years ago, humans started speaking and we’ve not shut up since. Sometimes, though, we struggle to remember the name of an object, a place, or a person we want to talk about. The technical term for this phenomenon is “lethologica”.

The Guardian - US

Leading neurosurgeon calls on Biden to undergo testing and release results

Amid wide speculation about president’s health, Sanjay Gupta says he believes cognitive exam is warranted

Dynamite News

Study finds how neurological symptoms associated with aura, migraine

For the first time, new research explains the relationship between the neurological symptoms of aura and the ensuing migraine, elucidating how a brain fluid flow disruption and a spreading wave of disruption cause headaches. Read further on Dynamite News:

The Independent UK

Scientists identify brain pathway that triggers migraines — bringing us closer to a cure

Discovery may help develop new class of migraine drugs

Zenger

Father Defies Brain Tumor, Scales Peak To Support Research‌

Andy Hampton overcomes tumor-induced paranoia, impaired senses, and gears up to climb for Brain Tumour Research, showing resilience.‌ ‌

Medical Daily

What Is Kisunla? Know All About New FDA-Approved Drug For Alzheimer's Disease

Kisunla manufactured by Eli Lilly could significantly slow cognitive decline in people with early symptomatic Alzheimer's disease, according to results of the company's clinical trials.

Top News

FDA Approves New Alzheimer's Drug To Slow Disease Progression

FDA approves Eli Lilly's donanemab for early Alzheimer's, offering hope for patients and caregivers. Treatment priced at 5 per vial.

1 … 22 23 24 25

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Australian Research Council

339 stories

ARC

320 stories

Brain Tumour Research

271 stories

TGA

245 stories

Imperial College London

the University of Birmingham

72 stories

Manchester Metropolitan University

62 stories

My Name5 Doddie Foundation

50 stories

the University of Copenhagen

17 stories

Tuskegee

12 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.